by 
Vitreous tamponades are medical devices and pharmaceutical formulations used to treat retinal detachment and other vitreoretinal pathologies. Vitreous tamponades act as sealing agents in the vitreous cavity and help reattach the retina back to the underlying retinal pigment epithelium thereby improving vision. The rising prevalence of retinal detachment primarily associated with aging, high near work, high myopia, and posterior vitreous detachment has significantly boosted demand for vitreous tamponades. The global vitreous tamponades market is estimated to be valued at US$ 76.00 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: One of the key trends gaining traction in the vitreous tamponades market is the growing adoption of silicone oils and perfluoropropane gases as tamponades. These tamponades have shown higher effectiveness compared to traditional tamponades such as gases. For instance, silicone oils have an specific gravity similar to that of the vitreous body which helps it remain localized to the vitreous cavity for longer duration. Perfluoropropane gases also provide longer retinal tamponade and do not require face down positioning post-surgery. Manufacturers are focusing on developing advanced formulations of silicone oils and perfluorocarbon liquids with reduced complications and improved safety profiles. This is expected to boost the demand for silicone oils and perfluorocarbon gases over the forecast period.
Porter’s Analysis
Threat of new entrants: The vitreous tamponades market has moderate threat of new entrants due to high capital requirement and stringent regulations.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and undifferentiated products.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to availability of substitutes and differentiation in products.
Threat of new substitutes: Threat of substitutes is low as there are limited alternatives to vitreous tamponades available.
Competitive rivalry: The vitreous tamponades market has high competitive rivalry among existing players due to established brand loyalty and differentiation.
Key Takeaways
The global vitreous tamponades market is expected to witness high growth over the forecast period.
Regional analysis: North America dominates the global market and is expected to grow at a CAGR of 2.4% during the forecast period. Increasing number of retinal surgeries being performed along with favorable reimbursement policies are major factors for market growth. Europe is the second largest region owing to growing elderly population and increasing cases of diabetes.
Key players: Key players operating in the vitreous tamponades market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH. Alcon Inc. and Dutch Ophthalmic Research Center International B.V. are the global leaders with significant market share.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
